|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01177 SINO BIOPHARM
Nominal 
3.310 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 6,065,734 | 6,265,155 | 5,366,294 | 5,325,336 |
| Net Cash from / (used in) Investing Activities | -- | (756,975) | (4,070,819) | (2,515,977) | (7,845,555) |
| Net Cash from / (used in) Financing Activities | -- | (6,548,990) | (3,186,390) | (3,225,263) | 2,233,188 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (1,240,231) | (992,054) | (374,946) | (287,031) |
| Cash & Cash Equivalents at beginning of period | -- | 8,654,805 | 9,599,537 | 10,624,194 | 10,631,210 |
| Effect of Foreign Exchange Rate Changes | -- | 90,524 | 47,322 | (649,711) | 280,015 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 7,505,098 | 8,654,805 | 9,599,537 | 10,624,194 |
| Remarks: | Real time quote last updated: 18/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,017,162 |
| %Change | 139.689% |
| EPS / (LPS) | RMB 0.164 |
| NBV Per Share (¥) | RMB 1.748 |